Delivery Order SPE2DE21D0007-SPE2D625F1LSF
Award Date 8/20/25
Potential Completion Date 8/25/25
Potential Value $4.3K
Federal Agency
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed Pricing Type
Fixed Price with Economic Price Adjustment
Place of Performance
Raritan, NJ 08869, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a $1,994.20 fixed-price delivery order awarded by the Defense agency Medical Supply Chain to Ortho-Clinical Diagnostics, Inc., a for-profit medical equipment manufacturer based in Raritan, New Jersey. The award is for the supply of "ANTI-JKA BIOCLONE 1X3ML", a specialized medical diagnostic product. Ortho-Clinical Diagnostics is a self-certified HUBZone joint venture and holds multiple federal contract vehicles, including indefinite delivery contracts and blanket purchase...
- The Defense Department's Medical Supply Chain has awarded a delivery order valued at $4.7K to Ortho-Clinical Diagnostics, Inc. for blood group serum, effective June 2, 2025, with an ultimate completion date of June 23, 2025. This fixed-price delivery order with economic price adjustment provisions will be performed at the contractor's facility in Raritan, New Jersey. The contract was awarded without set-aside designations, indicating open competition among qualified vendors. Ortho-Clinical...
- Ortho-Clinical Diagnostics, Inc. was awarded a delivery order contract on July 11, 2025, by the Medical Supply Chain division of the Department of Defense for the supply of Anti-A Bioclone 15x10ml reagents, valued at $1,156.61. The contract employs fixed-price pricing with economic price adjustment provisions and is scheduled for ultimate completion by August 1, 2025. The work will be performed at the company's facility in Raritan, New Jersey. No set-aside designation was used in this...
- Ortho-Clinical Diagnostics, Inc., headquartered in Raritan, New Jersey, was awarded a delivery order valued at $1,910.02 on August 6, 2025, for Anti-A Bioclone 15x10ml medical diagnostic reagents. The contract, which will be completed by August 27, 2025, was issued without a set-aside designation, indicating open competition. The funding originates from the Medical Supply Chain within the Department of Defense, with the place of performance located in Raritan, New Jersey. This delivery order...
- The U.S. Defense Department's Medical Supply Chain awarded a delivery order valued at $1,109.97 to Ortho-Clinical Diagnostics, Inc. for Anti-A Bioclone 15x10ML on August 1, 2025, with an ultimate completion date of August 6, 2025. The contract utilizes fixed-price pricing with economic price adjustment and carries no set-aside designation, indicating open competition. Performance will occur at the contractor's facility in Raritan, New Jersey. Ortho-Clinical Diagnostics, Inc., a for-profit...
- The U.S. Defense Department's Medical Supply Chain agency awarded a delivery order valued at $1,109.97 to Ortho-Clinical Diagnostics, Inc. for Anti-B Bioclone 15x10ML on August 11, 2025, with completion targeted for August 14, 2025. The contract utilizes fixed-price pricing with economic price adjustment and carries no set-aside designation, indicating open competition. Ortho-Clinical Diagnostics, headquartered in Raritan, New Jersey, is a for-profit medical equipment manufacturer specializing...
- Ortho-Clinical Diagnostics, Inc., headquartered in Raritan, New Jersey, has been awarded a delivery order valued at $3,104.52 for medical diagnostic supplies and equipment designated as "ANTI-S 1X3ML." The contract was awarded on August 19, 2025, with an ultimate completion date of August 22, 2025, and utilizes fixed-price pricing with economic price adjustment terms. The award was made without a set-aside designation, indicating open competition. Performance will take place at the...
- Ortho-Clinical Diagnostics, Inc. was awarded a delivery order valued at $1,871.28 for Anti-A Bioclone 15x10ml on July 21, 2025, with an ultimate completion date of July 24, 2025. The contract utilizes fixed-price pricing with economic price adjustment and was awarded without a set-aside designation, indicating open competition. The work will be performed in Raritan, New Jersey, and is funded by the Defense Health Agency's Medical Supply Chain, which supports critical medical diagnostic...
- Ortho-Clinical Diagnostics, Inc. was awarded a $1,156.61 fixed-price delivery order by the Defense Medical Supply Chain on July 14, 2025, for the supply of Anti-A Bioclone 15x10ml reagent products. The contract is scheduled for ultimate completion by August 4, 2025, and will be performed at the company's facility in Raritan, New Jersey. No small business set-aside designation was utilized for this award, indicating open competition among qualified vendors. This delivery order represents a...
- Ortho-Clinical Diagnostics Inc. has been awarded a $1,044.74 delivery order against an indefinite-delivery vehicle to provide ANTI-JKB BIOCLONE 1X3ML to the Defense Logistics Agency Troop Support Medical. As a self-certified HUBZone and manufacturer of medical goods, Ortho-Clinical Diagnostics will deliver the requested products from their Raritan, New Jersey location under a fixed price with economic price adjustment contract. No set-aside designation was applied to this order, which has a...